The global avian influenza vaccine market size is estimated to touch USD 735.22 million at a 7.25% CAGR between 2016-2025, reveals the Market Research Future (MRFR) report. Avian influenza, or bird flu, simply put, is a viral infection that spreads from one bird to another and may infect humans or other animals as well. Avian influenza has different strains that cause the infection, of which H5V1 is the most common affecting poultry animals. Its signs and symptoms may start 2-7 days of the infection, resting on the type. They in most cases, resemble that of conventional influenza, including shortness of breath, headache, muscle aches, sore throat, fever, and cough. Some also experience diarrhea, vomiting, or nausea. In most cases, people also experience mild eye infection, which is the sole indication of avian influenza. Besides, some life-threatening complications include heart problems, kidney dysfunction, respiratory failure, and pneumonia, among others. Avian influenza vaccine has several applications, including goose & duck, turkey, and chicken, and others.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/8769
Numerous factors are adding to the global avian influenza vaccine market growth. Such factors, according to the recent MRFR report, include the rising prevalence of avian influenza disease, the growing demand for poultry, and the on-going research on developing effective vaccines to prevent avian influenza.
On the contrary, lack of awareness and rapid deterioration of such vaccines are factors that can limit the global avian influenza vaccine market growth over the forecast period.
Avian Influenza Vaccine Market Segmentation
The MRFR report provides an inclusive segmental analysis of the global avian influenza vaccine market based on application and strain.
By strain, the global avian influenza vaccine market is segmented into H9, H7, and H5. Of these, the H5 segment will lead the market over the forecast period.
By application, the global avian influenza vaccine market is segmented into goose & duck, turkey, and chicken. Of these, the chicken segment will dominate the market over the forecast period.
Avian Influenza Vaccine Market Regional Analysis
By region, the global avian influenza vaccine market report covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East. Of these, the Asia Pacific region & the Middle East will spearhead the market over the forecast period. Factors adding to the market growth in these regions include increasing avian influenza outbreaks, rising poultry bird production, and different initiatives adopted by the government for effective & rapid response efforts towards emergent influenza viruses.
The avian influenza vaccine market in Europe is predicted to hold the second-largest share during the forecast period for the increasing dependence on poultry as a vital source of protein. Besides, animal husbandry practices, especially in Poland and Germany, and increasing veterinary product production are also adding market growth.
The avian influenza vaccine market in the Americas will have significant growth over the forecast period for the presence of several veterinary hospitals, rising expenditure on animal health, and expanding meat and poultry industry. Besides, improving efficiency of vaccines and growing support from the government to create awareness are also adding market growth.
Key Players
Notable players profiled in the global avian influenza vaccine market report include QYH BIOTECH COMPANY LIMITED (China), JOVAC (Jordan), Avimex Animal Health (Mexico), Medion (Indonesia), Merck Animal Health (US), Chengdu Tech-bank Biological Products Co., Ltd (China), PT JapfaComfeed Indonesia Tbk (Indonesia), Tianjin Ringpu Bio-Technology Co., Ltd (China), CAVAC (South Korea), FATRO S.P.A. (Italy), Zoetis (US), Yebio Bioengineering Co., Ltd (China), Ceva (US), Guangdong WenshiDahuanong Biotechnology Co., Ltd (China), and BoehringerIngelheim International GmbH (Germany). Expansion, product launch and approval, acquisition, and collaborations are the key strategies adopted by industry players to create a niche in the market.
Read Complete Report @ https://www.marketresearchfuture.com/reports/avian-influenza-vaccine-market-8769
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/avian-influenza-vaccine-market-8769